Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
AntiCan↑, TumCCA↑, Apoptosis↑, eff↑, Bcl-2↓, survivin↓, P21↑, p27↑, BAX↑, Cyt‑c↑, Casp3↑, PI3K↓, Akt↓, mTOR↓, Hif1a↓, PTEN↑, AMPKα↑, PDH↑, LDHA↓, antiOx↓, ROS↑, AntiCan↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
Wnt/(β-catenin)↓, β-catenin/ZEB1↓, TumAuto↑, Akt↓, mTOR↓, tumCV↓, TumCCA↑, TumAuto↑, p‑Akt↓, p‑p70S6↓, p‑4E-BP1↓,
| - |
vitro+vivo, |
CRC, |
SW480 |
|
|
|
- |
vitro+vivo, |
CRC, |
DLD1 |
|
|
|
- |
vitro+vivo, |
CRC, |
LS174T |
|
|
|
MMP↓, p‑Akt↓, TumCP↓, TumCI↓, NADH↓, HSP90↓, other↑, talin?,
miR-29b↑, miR-200b↑, MMP2↓, Zeb1↓, EMT↓, Apoptosis↑, ERK↓, MAPK↓, PI3K↓, Akt↓, MMPs↓, TumMeta↓,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
TumCG↓, TumCCA↑, MMP↓, Cyt‑c↑, Casp9↑, Casp3↑, p‑Akt↓, Bcl-2↓, BAX↑, Bax:Bcl2↑, 12LOX↓,
| - |
in-vitro, |
CRC, |
HT29 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, necrosis↑, AQPs↓, PTEN↑, PI3K↓, Akt↓, p‑Akt↓, mTOR↓, p‑mTOR↓,
Bcl-2↓, BAX↑, Akt↓, p70S6↓, PTEN↑, TSC2↑,
TumCP↓, Apoptosis↑, ChemoSen↑, PI3K↓, Akt↓, ERK↓,
antiOx↑, TumCCA↑, Apoptosis↑, Wnt↝, PI3K↝, MAPK↝, ROS↓, BioAv↝, P53↑, P21↑, CDK1↑, Ki-67↓, Ca+2↑, p‑Akt↓, mTOR↓, GSH↑, NRF2↑, HO-1↑, COX2↓, TNF-α↓, IL1β↓, IL6↓,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
AntiTum↑, Apoptosis↑, PI3K↓, Akt↓, TumCG↓, TumCCA↑, HSPD1 / HSP60↓, Ki-67↓, ChemoSen↑,
| - |
in-vitro, |
CRC, |
LoVo |
|
|
|
- |
in-vitro, |
CRC, |
SW48 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
E-cadherin↑, MMP2↓, MMP9↓, PI3K↓, Akt↓, IGF-1↓, Apoptosis↑, BAX↑, cl‑PARP↑, PARP↓, Bcl-2↓, TumCI↓,
Apoptosis↑, TumCCA↑, p‑Akt↓, Akt↓, Bcl-2↓, p‑BAD↓, BAD↑, cl‑PARP↑, ROS↑, HSP27↑, Beclin-1↑, p62↑, GPx1↓, GPx4↓,
eff↑, Akt↓, VEGFR2↓, STAT3↓, P53↓, Hippo↓, YAP/TEAD↑,
| - |
in-vitro, |
CRC, |
DLD1 |
|
|
|
- |
in-vitro, |
Nor, |
CCD841 |
|
|
|
tumCV↓, Apoptosis↑, selectivity↑, Casp↑, Bcl-2↓, MMP↓, TumCD↑, MAPK↓, JNK↓, PI3K↓, Akt↓, NF-kB↓, STAT↓, Diff↓, P53↑, PARP↓,
| - |
Review, |
CRC, |
NA |
|
|
|
- |
Review, |
Lung, |
NA |
|
|
|
- |
Review, |
BC, |
NA |
|
|
|
Inflam↑, ROS↓, ChemoSen↑, p‑PI3K↓, p‑Akt↓, QoL↑, GutMicro↑, chemoP↑, radioP↑, *NRF2↑, *Catalase↑, *GPx↑, *HO-1↑, *SOD↑, *TNF-α↓, *IL4↓, *IL6↓, ChemoSen↑, Appetite↑, cognitive↑, Pain↓, Sleep↑, other?,
| - |
in-vitro, |
CRC, |
Caco-2 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
PI3K↓, Akt↓, mTOR↓, TumCP↓, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, ROS↓, FOXO1↑, *toxicity∅, eff↑,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW48 |
|
|
|
- |
in-vitro, |
CRC, |
SW-620 |
|
|
|
TumCP↓, TumAuto↑, Akt↓, mTOR↓, ROS↑,
ROS↑, TrxR↓, eff↑, p‑Akt↓,
Inflam↓, AntiCan↑, Apoptosis↑, MMP↓, P53↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, NF-kB↓, IL6↓, IL1β↓, *antiOx↑, *lipid-P↓, *ROS↓, MAPK↓, JAK↓, STAT↓, PI3K↓, Akt↓, chemoP↑, ROS⇅, DNAdam↑, ChemoSen↝,
| - |
in-vivo, |
CRC, |
Caco-2 |
|
|
|
- |
vitro+vivo, |
CRC, |
CX-1 |
|
|
|
Apoptosis↑, PI3K↓, Akt↓, P53↑, BAX↑, Bax:Bcl2↑, p‑PARP↑, TumCMig↓,
Akt↓, β-catenin/ZEB1↓, cycD1/CCND1↓, survivin↓, Apoptosis↑, ROS↑,
TumCP↓, p‑PI3K↓, p‑Akt↓, p‑GSK‐3β↓, β-catenin/ZEB1↓, COX2↓, PGE2↓, EP2↓, EP4↓,
ChemoSen↑, *Half-Life↝, *BioAv↝, *antiOx↑, *Inflam↓, *hepatoP↑, TumCP↓, TumCCA↑, Apoptosis↑, angioG↑, selectivity↑, JNK↑, p38↑, p‑NF-kB↑, ERK↓, PI3K↓, PTEN↑, Akt↓, mTOR↓, EMT↓, Twist↓, E-cadherin↓, ROS⇅, *Catalase↑, *SOD↑, *GSTA1↑, *GPx↑, *PGE2↓, *IL1β↓, *COX2↓, *MMP13↓, MMPs↓, TumMeta↓, VEGF↓, STAT3↓, BAX↑, Bcl-2↑, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, survivin↓, cMyc↓, cycD1/CCND1↓, p27↑, P21↑, GSK‐3β↓, β-catenin/ZEB1↓, chemoP↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW48 |
|
|
|
Glycolysis↓, Warburg↓, HK2↓, ATP↓, NADPH↓, PI3K↓, Akt↓, TumCP↓, E-cadherin↑, N-cadherin↓, Hif1a↓, PKM2↓, GlucoseCon↓, lactateProd↓, EMT↓,
Showing Research Papers: 1 to 24 of 24
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 24
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned ⓘ
HSPD1 / HSP60↓, 1,
Redox & Oxidative Stress ⓘ
antiOx↓, 1, antiOx↑, 1, GPx1↓, 1, GPx4↓, 1, GSH↑, 1, HO-1↑, 1, NADH↓, 1, NRF2↑, 1, ROS↓, 3, ROS↑, 5, ROS⇅, 2, TrxR↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MMP↓, 4,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, cMyc↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1, LDHA↓, 1, NADPH↓, 1, PDH↑, 1, PKM2↓, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 18, p‑Akt↓, 9, Apoptosis↑, 13, BAD↑, 1, p‑BAD↓, 1, BAX↑, 8, Bax:Bcl2↑, 2, Bcl-2↓, 8, Bcl-2↑, 1, Casp↑, 1, Casp3↑, 5, Casp7↑, 1, Casp9↑, 4, Cyt‑c↑, 2, Hippo↓, 1, JNK↓, 1, JNK↑, 1, MAPK↓, 3, MAPK↝, 1, necrosis↑, 1, p27↑, 2, p38↑, 1, survivin↓, 3, TumCD↑, 1, YAP/TEAD↑, 1,
Kinase & Signal Transduction ⓘ
AMPKα↑, 1, p70S6↓, 1, p‑p70S6↓, 1, TSC2↑, 1,
Transcription & Epigenetics ⓘ
other?, 1, other↑, 1, tumCV↓, 2,
Protein Folding & ER Stress ⓘ
HSP27↑, 1, HSP90↓, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, p62↑, 1, TumAuto↑, 3,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↓, 1, P53↑, 4, PARP↓, 2, p‑PARP↑, 1, cl‑PARP↑, 3,
Cell Cycle & Senescence ⓘ
CDK1↑, 1, cycD1/CCND1↓, 2, P21↑, 3, TumCCA↑, 7,
Proliferation, Differentiation & Cell State ⓘ
p‑4E-BP1↓, 1, Diff↓, 1, EMT↓, 3, EP2↓, 1, EP4↓, 1, ERK↓, 3, FOXO1↑, 1, GSK‐3β↓, 1, p‑GSK‐3β↓, 1, IGF-1↓, 1, mTOR↓, 7, p‑mTOR↓, 1, PI3K↓, 12, PI3K↝, 1, p‑PI3K↓, 2, PTEN↑, 4, STAT↓, 2, STAT3↓, 2, TumCG↓, 2, Wnt↝, 1, Wnt/(β-catenin)↓, 1,
Migration ⓘ
Ca+2↑, 1, E-cadherin↓, 1, E-cadherin↑, 2, Ki-67↓, 2, miR-200b↑, 1, miR-29b↑, 1, MMP2↓, 2, MMP9↓, 1, MMPs↓, 2, N-cadherin↓, 1, talin?, 1, TumCI↓, 3, TumCMig↓, 2, TumCP↓, 8, TumMeta↓, 2, Twist↓, 1, Zeb1↓, 1, β-catenin/ZEB1↓, 4,
Angiogenesis & Vasculature ⓘ
angioG↑, 1, Hif1a↓, 2, VEGF↓, 1, VEGFR2↓, 1,
Barriers & Transport ⓘ
AQPs↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 2, IL1β↓, 2, IL6↓, 2, Inflam↓, 1, Inflam↑, 1, JAK↓, 1, NF-kB↓, 2, p‑NF-kB↑, 1, PGE2↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 1, ChemoSen↑, 5, ChemoSen↝, 1, eff↑, 4, selectivity↑, 2,
Clinical Biomarkers ⓘ
GutMicro↑, 1, IL6↓, 2, Ki-67↓, 2,
Functional Outcomes ⓘ
AntiCan↑, 3, AntiTum↑, 1, Appetite↑, 1, chemoP↑, 3, cognitive↑, 1, Pain↓, 1, QoL↑, 1, radioP↑, 1, Sleep↑, 1,
Total Targets: 144
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, Catalase↑, 2, GPx↑, 2, GSTA1↑, 1, HO-1↑, 1, lipid-P↓, 1, NRF2↑, 1, ROS↓, 1, SOD↑, 2,
Migration ⓘ
MMP13↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IL1β↓, 1, IL4↓, 1, IL6↓, 1, Inflam↓, 1, PGE2↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 1, Half-Life↝, 1,
Clinical Biomarkers ⓘ
IL6↓, 1,
Functional Outcomes ⓘ
hepatoP↑, 1, toxicity∅, 1,
Total Targets: 22
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:4 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page